Middle ear infection. Acute suppurative otitis media
Conditions
Interventions
Intervention 1: Group 1: Suction clearance and once a layer of topical Clotrimazole cream 1% made by Pars Daru pharmaceutical corporation in the ear canal. Intervention 2: Group 2: Use of suction clea
Treatment - Drugs
Group 1: Suction clearance and once a layer of topical Clotrimazole cream 1% made by Pars Daru pharmaceutical corporation in the ear canal
Group 2: Use of suction clearance and once a layer of topical clotrimazole (made by Pars Daru Pharmaceutical Corporation) and Ceftizoxime powder (made by Jaber ebn e Hayan Pharmaceutical corporation)
Sponsors
Vice Chancellor for research of Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with otomycosis accompanied with ruptured tympanic membrane. Exclusion criteria: Patients with immunosuppresion; Uncontrolled diabetic patients; Bacterial otitis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The survay of clinical symptoms (pain, swelling, discharge and itching. Timepoint: 2 weeks after start of treatment. Method of measurement: Clinical and Laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity to drug(s). Timepoint: 2 weeks after start of treatment. Method of measurement: Patient complaints and investigation by a physician. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeid Mahdavi Omran
Babol University of Medical Sciences
Outcome results
None listed